Understanding Side Effects: Wegovy vs Mounjaro Comparison
Does Wegovy Have Less Side Effects Than Mounjaro - Clinical Evidence
When examining whether Wegovy has fewer side effects than Mounjaro, clinical trial data reveals remarkably similar side effect profiles between both treatments. In the STEP trials for Wegovy (semaglutide), the most commonly reported side effects included nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%). Mounjaro's SURMOUNT trials showed comparable rates with nausea affecting 20-84% of patients depending on dose, alongside similar gastrointestinal effects. Both prescription-only medicines work by targeting gut hormones that regulate appetite, which explains why their side effect patterns are so alike. The key difference lies in their mechanisms - Wegovy acts solely on GLP-1 receptors, whilst Mounjaro targets both GIP and GLP-1 receptors as a dual agonist.
What's particularly important to understand about whether Wegovy has less side effects than Mounjaro is that individual tolerance varies significantly between patients. Some people may experience fewer side effects with Wegovy's single-target approach, whilst others might tolerate Mounjaro's dual mechanism better. Both treatments typically see side effects diminish over the first few weeks as your body adjusts to the medication. At EverydayMeds (GPhC #9012878), our prescribers can discuss your medical history and help determine which treatment profile may be most suitable for your circumstances, with both options readily available in our UK stock.
Wegovy vs Mounjaro Side Effects - Pricing and Immediate Availability
For patients considering whether Wegovy has less side effects than Mounjaro, cost and availability are practical factors alongside clinical considerations. Wegovy is immediately available at EverydayMeds starting from £79.99 for the 0.25mg starter dose, with our comprehensive bundle options including the Intro Duo (0.25mg & 0.5mg) for £169.99. New customers can apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to access these competitive prices. Unlike many UK pharmacies experiencing supply constraints, we maintain full stock levels across all five Wegovy doses with assured next-day cold-chain delivery once prescribed. Our streamlined process means you can begin treatment within days rather than weeks, allowing you to start managing potential side effects under proper medical supervision.
The pricing structure reflects the escalating dose schedule required for both treatments, though Wegovy's established supply chain through Novo Nordisk provides more predictable availability than some alternatives. When weighing up whether Wegovy has fewer side effects than Mounjaro, the ability to start treatment promptly and maintain consistent dosing is crucial for minimising side effects through proper dose escalation. Our bundles like the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 ensure continuity of treatment, which is essential since abrupt dose changes can increase the likelihood of gastrointestinal side effects with any GLP-1 based therapy.
Clinical Trial Data on Wegovy Side Effects vs Mounjaro
The question of whether Wegovy has less side effects than Mounjaro has been examined through extensive clinical trials, though direct head-to-head studies remain limited. According to Wilding et al., NEJM, 2021, Wegovy's STEP programme demonstrated that most side effects were mild to moderate and decreased over time. Nausea, the most common side effect, typically peaked during the first 8 weeks before subsiding as patients adapted to their maintenance dose. The structured dose escalation from 0.25mg to 2.4mg over 16 weeks was specifically designed to minimise these initial side effects whilst allowing the body to gradually adjust to semaglutide's appetite-regulating effects.
Comparative analysis suggests that both treatments share similar discontinuation rates due to side effects, indicating that neither Wegovy nor Mounjaro definitively has fewer side effects overall. However, the timing and intensity of side effects may vary between individuals due to the different receptor mechanisms involved. Some patients report that Wegovy's singular GLP-1 action provides a more predictable side effect profile, whilst others find Mounjaro's dual pathway approach suits them better, highlighting why personalised prescriber guidance is essential when determining which treatment option may be most appropriate.
How Wegovy Works and Its Side Effect Profile
Understanding how Wegovy works helps explain its side effect pattern and why the question "does Wegovy have less side effects than Mounjaro" depends on individual physiology. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 produced in your intestines after eating. This hormone signals to your brain that you're full, reduces gastric emptying (slowing food movement through your stomach), and decreases glucagon release from the pancreas. These mechanisms naturally lead to reduced appetite and enhanced satiety after smaller meals, but they also explain why the most common side effects affect the digestive system. The slowed gastric emptying that helps you feel full longer can initially cause nausea, particularly when combined with large meals or high-fat foods during the adjustment period.
Streamlined Ordering Process for Both Treatment Options
When deciding whether Wegovy has fewer side effects than Mounjaro, access to rapid medical assessment and treatment initiation can significantly impact your experience with either medication. Our 3-minute online clinical assessment covers your medical history, current medications, weight management goals, and any previous experiences with similar treatments. Following submission, our qualified prescribers review your application within 3 working days (or 24 hours with express service) to determine the most appropriate treatment option and starting protocol. Once approved, your medication is dispatched via next-day delivery using specialised cold-chain packaging to maintain the 2-8°C storage requirements. This efficient process means you can begin treatment quickly with proper medical oversight, which is crucial for monitoring and managing any initial side effects that may occur with either Wegovy or Mounjaro.
Storage Advantages and Practical Considerations
One practical advantage when comparing whether Wegovy has less side effects than Mounjaro relates to storage convenience, which can indirectly impact treatment adherence and side effect management. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from the refrigerator, compared to Mounjaro's 21-day limit. This extended room temperature stability makes Wegovy more suitable for travel, work situations, or lifestyle circumstances where refrigeration access may be limited. Consistent dosing schedules are crucial for minimising side effects with any GLP-1 therapy, so this storage flexibility can help maintain regular injection timing even when away from home. The FlexTouch pen design also provides precise dose delivery, ensuring you receive exactly the prescribed amount each week as you progress through the escalation schedule from 0.25mg to your maintenance dose.
Side Effect Management Strategies for Both Treatments
Regardless of whether Wegovy has fewer side effects than Mounjaro in your individual case, both treatments require similar management strategies to minimise gastrointestinal discomfort during the initial weeks. Starting with smaller, more frequent meals rather than large portions works with both medications' appetite-suppressing effects whilst reducing nausea risk. Avoiding high-fat, greasy, or heavily spiced foods during the first month can significantly improve tolerance, as these foods are harder to digest when gastric emptying is slowed. Staying well-hydrated and timing your weekly injection consistently (same day, similar time) helps your body establish a routine that minimises side effect fluctuations.
The escalating dose schedule built into both Wegovy and Mounjaro protocols serves as the primary side effect prevention strategy, allowing your digestive system to gradually adapt to increased hormone levels. Most patients find that initial side effects like nausea or mild stomach discomfort resolve within 4-6 weeks of reaching each new dose level. Our clinical team at EverydayMeds provides ongoing support throughout your treatment journey, helping you optimise timing, dietary choices, and injection techniques to maximise comfort whilst achieving your weight management goals alongside a reduced-calorie diet and increased physical activity.
Making Your Treatment Choice with Expert Guidance
The question of whether Wegovy has less side effects than Mounjaro ultimately requires personalised medical assessment rather than a universal answer. Both treatments are available immediately through EverydayMeds with no waiting lists or supply constraints, allowing you to start your chosen therapy without delay. New customers can use discount code FIRST40 at checkout, whilst returning patients apply DOSE25 to access our competitive pricing structure. Our GPhC-registered pharmacy (#9012878) ensures all medications are sourced directly from licensed manufacturers and stored under optimal conditions until dispatch. The combination of immediate availability, expert prescriber support, and comprehensive patient guidance makes EverydayMeds your trusted partner in weight management, whether you choose Wegovy or determine that Mounjaro might be more suitable for your individual circumstances and medical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
